Showing 821-830 of 1403 results for "".
Genetic Testing in Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/genetic-testing-in-neuromuscular-disorders/31549/Understanding ordering and interpretation of genetic tests is paramount for clinical management.The Multiple Sclerosis Prodrome: Past, Present, and Future
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-multiple-sclerosis-prodrome-past-present-and-future/31973/Multiple sclerosis may cause symptoms and disability prior to classically defined disease onset.Gene Therapy for Parkinson’s Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/gene-therapy-for-parkinsons-disease/31574/Gene therapies can be safely delivered; the questions of when, where, and why to use them remains.Dementia Insights: Diagnosis and Management of Dementia With Lewy Bodies
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-diagnosis-and-management-of-dementia-with-lewy-bodies/32136/Knowledge of the latest research findings will equip neurologists with the clinical insight necessary to navigate the complexities of dementia with Lewy bodies, enhancing patient care and outcomes.Challenge Case Report: Acute Onset of Expressive Aphasia, Visual Disturbances, and Severe Headache
https://practicalneurology.com/programs/practical-neurology/challenge-case-report-acute-onset-of-expressive-aphasia-visual-disturbances-and-severe-headache/33146/The differential diagnosis in the setting of leptomeningeal enhancement is broad, but when seen in association with an expansile intraparenchymal mass, there should be high suspicion for a neoplastic process.Spinal Muscular Atrophy is Now a Treatable Genetic Condition
https://practicalneurology.com/diseases-diagnoses/neuromuscular/spinal-muscular-atrophy-is-now-a-treatable-genetic-condition/32025/Multiple therapy options are available for the treatment of people with spinal muscular atrophy, a genetic disorder presenting with a wide range of symptoms and severity.Neurologic Complications of Globally Prevalent Infectious Disorders: A Focus on Syphilis, Cysticercosis, and Tuberculosis
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/neurologic-complications-of-globally-prevalent-infectious-disorders-a-focus-on-syphilis-cysticercosis-and-tuberculosis/32153/In the presence of CNS infections, neurologists should have a high index of suspicion for syphilis, tuberculosis, or cysticercosis, especially in people from endemic areas and immunocompromised individuals.Kappa Free Light Chains in the 2024 McDonald Criteria: What Neurologists Need to Know
https://practicalneurology.com/programs/practical-neurology/kappa-free-light-chains-in-the-2024-mcdonald-criteria/60979/The revised McDonald diagnostic criteria for multiple sclerosis now recognize kappa free light chains (KFLC) in cerebrospinal fluid as an alternative to oligoclonal bands, providing a quantitative and automated measure of intrathecal immunoglobulin synthesis.Epilepsy Essentials: Screening for Lennox-Gastaut Syndrome
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-screening-for-lennox-gastaut-syndrome/31910/A screening tool for Lennox-Gastaut syndrome may reduce time from presentation to diagnosis for earlier treatment and potentially improved outcomes.Stroke Snapshot: Incorporating Artificial Intelligence in Stroke Management: Redefining State of the Art
https://practicalneurology.com/diseases-diagnoses/stroke/stroke-snapshot-incorporating-artificial-intelligence-in-stroke-management-redefining-state-of-the-art/32033/Artificial intelligence and machine learning tools can augment stroke management across the continuum of care, including prevention, prognostication, neuroimaging, diagnosis, treatment, and recovery.